Eating and swallowing issues, along with meal planning and prep, can become challenging due to MS symptoms such as fatigue ...
Multiple sclerosis (MS) is a disease that affects the brain and spinal cord. It happens when the body’s immune system ...
Experts in Australia and New Zealand have published the first consensus guidelines for the care of adults with MS in those ...
While the continued erosion of Biogen’s multiple sclerosis franchise and weaker-than-expected 2025 guidance doesn’t seem to ...
Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...
The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.
ANI Pharmaceuticals offers an asymmetric opportunity in small-cap pharma, with a niche in generics, rare disease treatments, ...
For Tammy Gusher Delgado, 56, the decision to join a clinical trial was clear. With a recent multiple sclerosis diagnosis and a clinical trial offering either the study drug or an approved ...
Joe Walsh is now testing a new treatment using a nasal spray, the medication inside is called Foralumab. He is the first patient with Alzheimer's to try it. The Walsh family is hopeful. Foralumab is ...
The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, and will help health professionals navigate a treatment landscape that has ...
Scott, an internationally recognized neurologist and leader in multiple sclerosis (MS) research and clinical care, has been awarded the 2024 MS Research Award by MS Australia.
The first clinical consensus statement for managing multiple sclerosis (MS) in Australia and New Zealand has been released, and will help health ...